127 related articles for article (PubMed ID: 23377316)
1. Soluble endothelial protein C receptor levels and protein C activity in patients with acute ST-segment elevation myocardial infarction.
Tanalp AC; Oduncu V; Erkol A; Gözübüyük G; Ozveren O; Dündar C; Canbay A; Kirma C
Coron Artery Dis; 2013 May; 24(3):209-16. PubMed ID: 23377316
[TBL] [Abstract][Full Text] [Related]
2. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings.
Arslan U; Kocaoğlu I; Balci MM; Gülkan B; Falay MY; Temizhan A
Coron Artery Dis; 2013 Aug; 24(5):404-11. PubMed ID: 23612365
[TBL] [Abstract][Full Text] [Related]
3. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
[TBL] [Abstract][Full Text] [Related]
4. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
[TBL] [Abstract][Full Text] [Related]
5. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
[TBL] [Abstract][Full Text] [Related]
6. Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
Nishiguchi T; Tanaka A; Taruya A; Emori H; Ozaki Y; Orii M; Shiono Y; Shimamura K; Kameyama T; Yamano T; Yamaguchi T; Matsuo Y; Ino Y; Kubo T; Hozumi T; Hayashi Y; Akasaka T
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2460-2467. PubMed ID: 27687605
[TBL] [Abstract][Full Text] [Related]
7. Lower plasma protein C activity is associated with early myocardial necrosis and no-reflow phenomenon in patients with ST elevation myocardial infarction.
Stankovic S; Obradovic S; Dzudovic B; Djenic N; Romanovic R; Jovic Z; Spasic M; Djuric O; Malovic D; Stavric M; Subota V
Acta Cardiol; 2019 Aug; 74(4):331-339. PubMed ID: 30204553
[No Abstract] [Full Text] [Related]
8. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
Liu ZB; Fu XH; Wei G; Gao JL
Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
[TBL] [Abstract][Full Text] [Related]
9. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of intraplatelet melatonin levels to predict angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Jimenez-Sosa A; Avanzas P; Bosa-Ojeda F; Kaski JC
Am J Cardiol; 2010 Dec; 106(11):1540-4. PubMed ID: 21094352
[TBL] [Abstract][Full Text] [Related]
11. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
Choo EH; Kim PJ; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
Coron Artery Dis; 2014 Aug; 25(5):392-8. PubMed ID: 24625688
[TBL] [Abstract][Full Text] [Related]
12. Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Lai HM; Xu R; Yang YN; Ma YT; Li XM; Zhao Q; Chen QJ; Zhai H; Liu F; Chen BD
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():724-33. PubMed ID: 25630273
[TBL] [Abstract][Full Text] [Related]
13. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
[TBL] [Abstract][Full Text] [Related]
14. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
[TBL] [Abstract][Full Text] [Related]
16. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
17. [Relation of admission neutrophil/lymphocyte ratio to angiographic no-reflow phenomenon in patients with ST-elevated myocardial infarction undergoing primary coronary intervention].
Niu X; Zhang Y; He S; Chen D; Yan D; Yao Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jul; 35(7):856-60. PubMed ID: 25294082
[TBL] [Abstract][Full Text] [Related]
18. Effects of liraglutide on no-reflow in patients with acute ST-segment elevation myocardial infarction.
Chen WR; Tian F; Chen YD; Wang J; Yang JJ; Wang ZF; Da Wang J; Ning QX
Int J Cardiol; 2016 Apr; 208():109-14. PubMed ID: 26849684
[TBL] [Abstract][Full Text] [Related]
19. Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction.
Niccoli G; Milardi D; D'Amario D; Fracassi F; Grande G; Panico RA; Roberto M; Mirizzi AM; Canu G; De Marinis L; Carrozza C; Pontecorvi A; Crea F
Eur J Prev Cardiol; 2015 Jul; 22(7):855-63. PubMed ID: 24821730
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
Hong SN; Ahn Y; Hwang SH; Yoon NS; Lee SR; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Aug; 100(4):631-4. PubMed ID: 17697819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
